Substack · Wolf's Substack · Wolf Of Oakville
Biorem Inc. ($BRM.V) FINS Review
Q2 2026
Since publication +4.5% α +3.9 pp vs S&P/TSX · CAD
No region · 1 entry · 1 publication
No entry states a stance.
Free during launch: log in or sign up with your email to see it.
Sign up freeSubstack · Wolf's Substack · Wolf Of Oakville
Q2 2026
Since publication +4.5% α +3.9 pp vs S&P/TSX · CAD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.